ACCREDITATION
Program Overview
The goal of this program is to deliver a comprehensive educational update that will highlight the most clinically relevant advances in the management of GI disorders.
Target Audience
This activity has been designed to meet the educational needs of health care professionals, including physicians, community-based gastroenterologists, nurse practitioners, physician assistants, and nurses who are currently managing and treating patients with GI disorders.
Learning Objectives
Upon completion of this activity, participants should be able to:
-
Describe new data as it pertains to the implications and options for patients as it pertains to their continued care
-
Apply updated guidelines for care for chronic liver and GI related diseases
-
Discuss future directions of therapeutics, diagnostics, and technology in the management of GI and liver diseases
​​
In support of improving patient care, this activity has been planned and implemented by Medical Education Resources (MER) and the Southern California Society of Gastroenterology (SCSG). MER is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
ACCME Statement
Medical Education Resources designates this live activity for a maximum of 9.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
MOC Designation
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 9.0 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Disclosure of Relevant Financial Relationships
Medical Education Resources ensures balance, independence, objectivity, and scientific rigor in all our educational activities. In accordance with this policy, MER identifies relevant financial relationships with its instructors, content managers, and other individuals who are in a position to control the content of an activity. Reported relevant financial relationships are mitigated by MER to ensure that all scientific research referred to, reported, or used in a CE activity conforms to the generally accepted standards of experimental design, data collection, and analysis. MER is committed to providing learners with high-quality CE activities that promote improvements or quality in health care and not the business interest of an ineligible company.
MER and the Southern California Society of Gastroenterology (SCSG) planners have no relevant financial relationships to disclose.
Disclaimer
The content and views presented in this educational activity are those of the authors and do not necessarily reflect those of Medical Education Resources, the Southern California Society of Gastroenterology (SCSG). The authors have disclosed if there is any discussion of published and/or investigational uses of agents that are not indicated by the FDA in their presentations. Before prescribing any medicine, primary references and full prescribing information should be consulted. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. The information presented in this activity is not meant to serve as a guideline for patient management.
Fee information: Click here to view registration fees.
Jointly provided by the Medical Education Resources and
the Southern California Society of Gastroenterology (SCSG).
​
​
​
​
​
​
This activity is supported by an educational grant from educational grant from Salix Pharmaceuticals.
​
​